Responsibility02.25.2021
Amgen commits to doubling supplier diversity spend by 2023 as it builds more external relationships with advocacy groups in the context of health equity.
Science and Innovation02.24.2021
KRAS G12C
Learn more about our pioneering research in taking on one of cancer research’s toughest challenges, and hear first-hand from patients and Amgen scientists.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
